What's breaking now, across thousands of outlets.
The fall IPO train is boarding. ADARx Pharmaceuticals, a well-funded siRNA biotech in Phase 3, plans to raise about $318 million in its proposed initial public offering, according to its
We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.
IonQ is growing much faster than the GPU giant, but there's a catch.
Nigeria has secured three significant capital-market milestones in nine days, putting its economic reforms before domestic and international investors at read more Three market wins in nine days as…
Fallende Ölpreise dämpfen die Zinssorgen an den Finanzmärkten. Im Zentrum der Woche stehen das Treffen zwischen US-Präsident Donald Trump und Chinas Staatschef Xi Jinping.
As U.S. citizenship application fees rise and renunciation fees have fallen, this article asks whether American citizenship is still a prize—or is it a burden.
